References
- Back EE, Waldrop AE, Brady KT. Anxiety in the context of substance abuse. In: Stein D, Hollander E, Rothbaum BO, eds. Textbook of anxiety disorders. 2nd ed. Arlington, VA: American Psychiatric Publishing Inc.; 2009: 665–680
- Brady KT, McCauley JL, Back SE. The comorbidity of post-traumatic-stress disorder (PTSD) and substance use disorders. In: El-Guebaly N, Carrà G, Galanter M, eds. Textbook of addiction treatment: international perspectives. Heidelberg New York Dordrecht London: Springer; Jan 2015: 1985–2004
- Bogenschultz M, Bhatt S, Bohan J, Foster B, Romo P, Wilcox CE, Tonigan JS. Co-administration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study. Am J Drug Alco Abuse 2016. doi: 10.3109/00952990.2016.1168430.
- Lader M. Benzodiazepines revisited–will we ever learn? Addiction 2011;106:2086–2109.
- Gray KM, Carpenter MJ, Baker NL, DeSantis SM, Kryway E, Hartwell KJ, McRae-Clark AL, Brady KT. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry 2012;169:805–812.